189 related articles for article (PubMed ID: 19117988)
1. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.
Cohen EE; Zhu H; Lingen MW; Martin LE; Kuo WL; Choi EA; Kocherginsky M; Parker JS; Chung CH; Rosner MR
Cancer Res; 2009 Jan; 69(1):65-74. PubMed ID: 19117988
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b-protein kinase Cα positive feedback loop and inhibiting Rac1 activation.
Wang Z; Humphries B; Xiao H; Jiang Y; Yang C
J Biol Chem; 2014 Jun; 289(26):18373-86. PubMed ID: 24841200
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.
von Brandenstein M; Pandarakalam JJ; Kroon L; Loeser H; Herden J; Braun G; Wendland K; Dienes HP; Engelmann U; Fries JW
Am J Pathol; 2012 May; 180(5):1787-97. PubMed ID: 22429968
[TBL] [Abstract][Full Text] [Related]
5. PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck.
Zhen-jin Z; Peng L; Fa-yu L; Liyan S; Chang-fu S
Mol Cell Biochem; 2011 Nov; 357(1-2):181-7. PubMed ID: 21735098
[TBL] [Abstract][Full Text] [Related]
6. PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival.
Cameron AJ; Procyk KJ; Leitges M; Parker PJ
Int J Cancer; 2008 Aug; 123(4):769-79. PubMed ID: 18508315
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium.
Hao F; Pysz MA; Curry KJ; Haas KN; Seedhouse SJ; Black AR; Black JD
J Biol Chem; 2011 May; 286(20):18104-17. PubMed ID: 21454537
[TBL] [Abstract][Full Text] [Related]
8. Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.
Poi MJ; Knobloch TJ; Sears MT; Uhrig LK; Warner BM; Weghorst CM; Li J
Anticancer Res; 2014 Jul; 34(7):3285-92. PubMed ID: 24982332
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification.
Magnifico A; Albano L; Campaner S; Campiglio M; Pilotti S; Ménard S; Tagliabue E
Cancer Res; 2007 Jun; 67(11):5308-17. PubMed ID: 17545611
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer.
Kyuno D; Kojima T; Yamaguchi H; Ito T; Kimura Y; Imamura M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
Carcinogenesis; 2013 Jun; 34(6):1232-43. PubMed ID: 23389293
[TBL] [Abstract][Full Text] [Related]
11. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.
Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH
Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Kuo WL; Liu J; Mauceri H; Vokes EE; Weichselbaum R; Rosner MR; Cohen EE
Mol Cancer Ther; 2010 Oct; 9(10):2814-24. PubMed ID: 20876745
[TBL] [Abstract][Full Text] [Related]
13. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
Xia W; Ni J; Zhuang J; Qian L; Wang P; Wang J
Int J Biochem Cell Biol; 2016 Feb; 71():1-11. PubMed ID: 26646106
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.
Johnson J; Albarani V; Nguyen M; Goldman M; Willems F; Aksoy E
J Biol Chem; 2007 May; 282(20):15022-32. PubMed ID: 17296604
[TBL] [Abstract][Full Text] [Related]
15. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
[TBL] [Abstract][Full Text] [Related]
16. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
17. MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.
Liu MD; Wu H; Wang S; Pang P; Jin S; Sun CF; Liu FY
Gene; 2018 Mar; 646():1-7. PubMed ID: 29278769
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
19. MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma.
Zhao Y; Ling Z; Hao Y; Pang X; Han X; Califano JA; Shan L; Gu X
Oncotarget; 2017 Apr; 8(15):25005-25020. PubMed ID: 28212569
[TBL] [Abstract][Full Text] [Related]
20. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
